Global Health Limited, operating under the renowned Medanta brand, announced its audited financial results for the fourth quarter and full financial year ending March 31, 2026, on May 14, 2026. The Board of Directors recommended a final dividend of Rs. 0.50 per equity share (25%) for the fiscal year, pending shareholder approval. Operationally, the company appointed Kedar Ashok Apte as Chief Marketing & Growth Officer and Jagdeep Singh as General Counsel. These leadership changes coincide with the conclusion of the tenure for Richa Singh, who resigned as a Senior Management Personnel effective May 20, 2026.

Global Health Limited is a premier multi-specialty healthcare provider in India, founded by Dr. Naresh Trehan. The company operates a network of super-specialty hospitals under the “Medanta” brand, focusing on advanced medical research and high-end patient care. In early 2026, the company expanded its footprint by entering a 400-bed multi-specialty hospital project in Varanasi and acquiring a 79-bed specialized oncology facility in Indore.

All amounts are in Millions.